Search

Author/Creator Nolan, Luke

2. CD8 T‐cell‐mediated cerebellitis directed against Purkinje cell antigen after ipilimumab for small cell lung cancer. (8th August 2021)

Authors:
Hardwick, Marc; Nolan, Luke; Nicoll, James A. R.; Jogai, Sanjay; Arriola, Edurne; Joseph‐Pietras, Debora; Norman, Jeanette; Ottensmeier, Christian H. H.; Galea, Ian
Journal:
Neuropathology & applied neurobiology
Issue:
Volume 48:Number 2(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First‐Line Therapy for Extensive‐Stage SCLC. Issue 9 (September 2016)

Authors:
Arriola, Edurne; Wheater, Matthew; Galea, Ian; Cross, Nadia; Maishman, Tom; Hamid, Debbie; Stanton, Louise; Cave, Judith; Geldart, Tom; Mulatero, Clive; Potter, Vannessa; Danson, Sarah; Woll, Pennella J.; Griffiths, Richard; Nolan, Luke; Ottensmeier, Christian
Journal:
Journal of thoracic oncology
Issue:
Volume 11:Issue 9(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. (3rd June 2019)

Authors:
Hardy-Werbin, Max; Rocha, Pedro; Arpi, Oriol; Taus, Álvaro; Nonell, Lara; Durán, Xavier; Villanueva, Xavier; Joseph-Pietras, Deborah; Nolan, Luke; Danson, Sarah; Griffiths, Richard; Lopez-Botet, Miguel; Rovira, Ana; Albanell, Joan; Ottensmeier, Christian; Arriola, Edurne
Journal:
Oncoimmunology
Issue:
Volume 8:Number 6(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗